GlassScriptPhysician profile
Richard Stuart Epter
NPI 1629047766
$31,329.83
in general payments reported to CMS, 2019-2025
28 companies · $5,860 in 2025
The $5,860 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $744 · 2021: $582 · 2022: $2,742 · 2023: $1,603 · 2024: $19K · 2025: $5,860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,925 · Education: $7,283 · Food and Beverage: $6,783 · Consulting Fee: $1,785 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $893 · Travel and Lodging: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,925.00 |
| Education | $7,282.80 |
| Food and Beverage | $6,782.66 |
| Consulting Fee | $1,785.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $892.50 |
| Travel and Lodging | $544.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $12,027.55 | 2020-2024 | Vyrsa V1, Senza |
| Painteq LLC | $9,211.03 | 2021-2024 | Painteq |
| Globus Medical, INC. | $3,278.96 | 2025 | Senza, Vyrsa V1, Vyrsa V1 |
| Boston Scientific Corporation | $2,164.40 | 2019-2025 | Intracept, Na, G4 Rf Generator |
| Spinal Simplicity, LLC | $2,042.68 | 2024-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $484.35 | 2019-2024 | Eterna |
| Biotronik Nro, INC. | $475.07 | 2025 | Prospera |
| Vertos Medical, INC. | $426.97 | 2021-2023 | Mild Device Kit |
| Stimwave Technologies Incorporated | $209.02 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $160.99 | 2021-2023 | Ztlido |
| Mml US, INC. | $128.90 | 2024 | Reactiv8 |
| Daiichi Sankyo INC. | $125.00 | 2019 | |
| Acacia Pharma INC | $110.16 | 2022 | |
| Nalu Medical, INC. | $94.17 | 2022 | |
| Curonix LLC | $86.40 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $47.56 | 2025 | Sprint Pns System |
| Mdd US Operations, LLC | $37.59 | 2019 | |
| Saluda Medical Americas, INC. | $34.04 | 2024 | Evoke |
| Arbor Pharmaceuticals, INC. | $32.29 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $30.07 | 2024 | Horizant |
| Pacira Therapeutics, INC. | $24.59 | 2019 | |
| Ibsa Pharma INC. | $20.90 | 2021 | |
| Averitas Pharma INC. | $16.97 | 2023 | Qutenza |
| Assertio Therapeutics, INC. | $14.15 | 2019 | |
| Pfizer INC. | $13.48 | 2019 | |
| Fidia Pharma USA INC. | $13.25 | 2020 | |
| Collegium Pharmaceutical, INC. | $12.16 | 2019 | |
| Kerecis Limited | $7.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Epter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.